Angelica Kohlmann is a prominent leader in the biotech and technology sectors, serving as Chair of the Board of Directors at Bloom Diagnostics and Kohlmann & Co AG, where Angelica is also a CEO and Co-Founder. Currently, Angelica holds key positions on the Board of Directors at Lonza, as well as leading the Innovation and Technology Committee and the Nomination and Compensation Committee. Additionally, Angelica is the President of the Swiss Technion Society and the Chairperson of the International Advisory Board at the Global Peter Drucker Forum. Angelica's academic credentials include an MD PhD from the University of Hamburg and ongoing studies at Harvard Business School, which enhance a robust background in innovation and management.